← Open Payments lookup

EDEN LEE: Open Payments

NPI 1023103215 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$511 in 18 payments from 9 companies in 2025. Trend: 2023 $388 · 2024 $342 · 2025 $511

Food & beverage: $511
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$112
Sumitomo Pharma America, Inc.1$109
Janssen Pharmaceuticals, Inc4$108
Alkermes, Inc.4$89
E.R. Squibb & Sons, L.L.C.1$26
Otsuka America Pharmaceutical, Inc.1$18
ABBVIE INC.1$18
Teva Pharmaceuticals USA, Inc.1$17
Sage Therapeutics, LLC1$14

Products named: INGREZZA, GEMTESA, INVEGA SUSTENNA, ARISTADA, COBENFY, REXULTI, VRAYLAR, UZEDY.

Industry payments across NV — which companies pay providers there.